Effect of San'ao Decoction(三拗汤) on the Airway Inflammation and Hyperresponsiveness in a Murine Model of Lipopolysaccharide-enhanced Asthma

Objective:San'ao Decoction(三拗汤,SAD),as a representative Chinese medicine(CM)formula, was chosen to evaluate the effect of airway inflammation and hyperresponsiveness on the lipopolysaccharide (LPS)enhanced asthma model.Methods:The asthma model was reproduced in the Balb/C mice sensitized by ovalbumi...

Full description

Saved in:
Bibliographic Details
Published in中国结合医学杂志:英文版 Vol. 17; no. 7; pp. 537 - 541
Main Author 顾鹏程 范欣生 蒋辰雪 许惠琴 俞晶华 唐于平
Format Journal Article
LanguageEnglish
Published 2011
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective:San'ao Decoction(三拗汤,SAD),as a representative Chinese medicine(CM)formula, was chosen to evaluate the effect of airway inflammation and hyperresponsiveness on the lipopolysaccharide (LPS)enhanced asthma model.Methods:The asthma model was reproduced in the Balb/C mice sensitized by ovalbumin(OVA),challenged by OVA and LPS.After Balb/C mice's administration of a dose(0.0024 g/kg)of dexamethasone acetate,and three doses(2.2 g/kg,4.4 g/kg and 8.8 g/kg)of SAD,airway inflammation and responsiveness were observed.The airway inflammation was detected by counting bronchoalveolar lavage fluid (BALF)cells and lung histopathology.Also,differential expressions of interferon-r(IFN-γ),interleukin-4(IL-4), and IL-5 in the supernatants of BALF were examined.The changes in airway responsiveness indicated by lung resistance(R_L)and stimulated by acetylcholine(Ach)were determined.Results:Small-dose SAD hardly inhibit airway inflammation or hyperresponsiveness in the LPS-enhanced asthma,while medium-dose and high-dose SAD significantly inhibited the airway hyperresponsiveness,and to some extent,reduced airway inflammation. Meanwhile,the small-dose,medium-dose,and high-dose SAD promoted Th1-type cytokines(IFN-γ)and reduced Th2-type cytokines(IL-4,IL-5)to different extents,which led to a Th1/Th2 balance.Conclusion:SAD has a good therapeutic effect on airway hyperresponsiveness in the LPS-enhanced asthma model,but its definite influence on airway inflammation is not remarkable.
Bibliography:San'ao Decoction, lipopolysaccharide, asthma
GU Peng-cheng, FAN Xin-sheng , JIANG Chen-xue , XU Hui-qin , YU Jing-hua , and TANG Yu-ping (1. Department of Pharmacology, Nanjing University of Chinese Medicine, Nanjing (210029), China; 2. Jiangsu Key Laboratory for Traditional Chinese Medicine Formulae Research, Nanjing University of Chinese Medicine, Nanjing (210046), China; 3. Clinical Trials Center, Nanjing University of Chinese Medicine, Nanjing (210046), China)
11-4928/R
Objective:San'ao Decoction(三拗汤,SAD),as a representative Chinese medicine(CM)formula, was chosen to evaluate the effect of airway inflammation and hyperresponsiveness on the lipopolysaccharide (LPS)enhanced asthma model.Methods:The asthma model was reproduced in the Balb/C mice sensitized by ovalbumin(OVA),challenged by OVA and LPS.After Balb/C mice's administration of a dose(0.0024 g/kg)of dexamethasone acetate,and three doses(2.2 g/kg,4.4 g/kg and 8.8 g/kg)of SAD,airway inflammation and responsiveness were observed.The airway inflammation was detected by counting bronchoalveolar lavage fluid (BALF)cells and lung histopathology.Also,differential expressions of interferon-r(IFN-γ),interleukin-4(IL-4), and IL-5 in the supernatants of BALF were examined.The changes in airway responsiveness indicated by lung resistance(R_L)and stimulated by acetylcholine(Ach)were determined.Results:Small-dose SAD hardly inhibit airway inflammation or hyperresponsiveness in the LPS-enhanced asthma,while medium-dose and high-dose SAD significantly inhibited the airway hyperresponsiveness,and to some extent,reduced airway inflammation. Meanwhile,the small-dose,medium-dose,and high-dose SAD promoted Th1-type cytokines(IFN-γ)and reduced Th2-type cytokines(IL-4,IL-5)to different extents,which led to a Th1/Th2 balance.Conclusion:SAD has a good therapeutic effect on airway hyperresponsiveness in the LPS-enhanced asthma model,but its definite influence on airway inflammation is not remarkable.
ISSN:1672-0415
1993-0402